Interventions to Facilitate Shared Decision-Making Using Decision Aids with Coronary Heart Disease Patients:

Haoyang Zheng1, Duo Zhang2, Wei Xiang1

  • 1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, China.

Insights

Shared decision-making (SDM) using patient decision aids improves knowledge and reduces conflict for coronary heart disease (CHD) patients. This approach enhances decision quality and treatment outcomes in CHD management.

Area of Science:

  • Cardiology
  • Health Decision Science
  • Evidence-Based Medicine

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality.
  • Managing CHD involves complex decisions regarding chest pain, treatments, and stent selection, often complicated by unstable patient conditions.
  • Shared decision-making (SDM) with decision aids can improve decision quality but has not been evaluated in CHD.

Purpose of the Study:

  • To systematically review and assess the effects of SDM interventions on patients with coronary heart disease.
  • To evaluate the impact of SDM on decision-making quality and treatment outcomes in CHD patients.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) of SDM interventions in CHD patients.
  • Searched multiple databases (PubMed, Embase, Cochrane, Web of Science, CNKI, Wan Fang) from inception to June 2022.
  • Primary outcomes: patient knowledge and decision conflict. Secondary outcomes: satisfaction, participation, trust, acceptance, quality of life, and psychological condition.

Main Results:

  • Ten studies involving 8244 retrieved articles were included.
  • SDM interventions significantly improved patient knowledge, decision satisfaction, participation, and medical outcomes compared to control groups.
  • SDM interventions effectively reduced decision-making conflict, with no significant impact on patient trust.

Conclusions:

  • SDM interventions, particularly using patient decision aids, are beneficial for improving decision-making quality and treatment outcomes in patients with CHD.
  • Further evaluation of SDM interventions in diverse settings is warranted to confirm these benefits.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
971
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.0K